[mepr-show rules=”18700″ unauth=”message”]
Overview: SD Biosensor is a global bio-diagnostic company that provides in vitro diagnostic products engrafted with innovative technologies and know-hows. Founded in 2005, the company’s line of business includes the manufacturing of medical, surgical, ophthalmic, and veterinary instruments and apparatus.
Test Name: STANDARD Q COVID-19 Ag
Testing Type: Rapid antigen test
Technology: STANDARD Q COVID-19 IgM/IgG Duo Test Kit is a rapid immunochromatography test designed for the qualitative presumptive detection of specific IgM and IgG to SARS-CoV-2 in humoral fluid.
Test Sample Type: Nasopharyngeal swab
Time to Result: 30 minutes
Testing Location: Anywhere
Complementary Products: Specimen: Nasopharyngeal swab
Effectiveness: Sensitivity: 84%, Specificity: 100% Based on 32 and 170 tests respectively
Current Status: Korea MFDS EUA – Brazil ANVISA – CE-IVD
Business Model: Private, funded through sale of IVD kits
Organization: Managing Director Hee Chang Ka. Worldwide offices in South Korea, India, and China. SD Biosensor offers the industry’s broadest range of tests focusing on all major disease areas including infectious disease, metabolism, cardiology, oncology and etc.
[/mepr-show]S